ADC Therapeutics (ADCT) Debt Ratio (2020 - 2026)

ADC Therapeutics (ADCT) has reported Debt Ratio for 7 consecutive years, with 0.4 the latest figure, recorded in Q1 2026.

• Quarterly Debt Ratio fell 4.98% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (down 4.98% YoY) and the FY2025 annual result came in at 0.36, up 1.23% from the prior year.
• Debt Ratio climbed to 0.4 in Q1 2026 per ADCT's latest filing, from 0.36 in the prior quarter.
• Over the last five years, Debt Ratio for ADCT reached as high as 0.42 in Q1 2025 and fell as low as 0.16 in Q1 2022.
• A 5-year average of 0.3 and a median of 0.32 in 2023 frame the typical range for Debt Ratio.
• The largest YoY upside for Debt Ratio was 91.41% in 2022 against a maximum downside of 5.3% in 2022.
• Year by year, Debt Ratio stood at 0.25 in 2022, then grew by 27.65% to 0.32 in 2023, then climbed by 11.07% to 0.35 in 2024, then increased by 1.23% to 0.36 in 2025, then grew by 11.08% to 0.4 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.4, 0.36, and 0.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.